Heart Test Laboratories (HSCS) Competitors $3.69 -0.12 (-3.15%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$3.90 +0.22 (+5.83%) As of 02/21/2025 07:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends HSCS vs. LYRA, ALUR, BLAC, LUCY, SSKN, IINN, INBS, POAI, BTCY, and CUTRShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include Lyra Therapeutics (LYRA), Allurion Technologies (ALUR), Bellevue Life Sciences Acquisition (BLAC), Innovative Eyewear (LUCY), STRATA Skin Sciences (SSKN), Inspira Technologies Oxy B.H.N. (IINN), Intelligent Bio Solutions (INBS), Predictive Oncology (POAI), Biotricity (BTCY), and Cutera (CUTR). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. Lyra Therapeutics Allurion Technologies Bellevue Life Sciences Acquisition Innovative Eyewear STRATA Skin Sciences Inspira Technologies Oxy B.H.N. Intelligent Bio Solutions Predictive Oncology Biotricity Cutera Heart Test Laboratories (NASDAQ:HSCS) and Lyra Therapeutics (NASDAQ:LYRA) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, community ranking, institutional ownership, earnings and analyst recommendations. Does the media refer more to HSCS or LYRA? In the previous week, Heart Test Laboratories' average media sentiment score of 0.00 equaled Lyra Therapeutics'average media sentiment score. Company Overall Sentiment Heart Test Laboratories Neutral Lyra Therapeutics Neutral Is HSCS or LYRA more profitable? Heart Test Laboratories has a net margin of 0.00% compared to Lyra Therapeutics' net margin of -6,635.76%. Heart Test Laboratories' return on equity of -117.76% beat Lyra Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -117.76% -84.09% Lyra Therapeutics -6,635.76%-125.07%-59.74% Which has better valuation & earnings, HSCS or LYRA? Heart Test Laboratories has higher earnings, but lower revenue than Lyra Therapeutics. Heart Test Laboratories is trading at a lower price-to-earnings ratio than Lyra Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$14.70K246.00-$6.61M-$7.91-0.47Lyra Therapeutics$1.56M8.63-$62.68M-$1.49-0.14 Do analysts recommend HSCS or LYRA? Heart Test Laboratories presently has a consensus price target of $13.50, indicating a potential upside of 265.85%. Lyra Therapeutics has a consensus price target of $4.50, indicating a potential upside of 2,087.65%. Given Lyra Therapeutics' higher possible upside, analysts clearly believe Lyra Therapeutics is more favorable than Heart Test Laboratories.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Lyra Therapeutics 1 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community prefer HSCS or LYRA? Lyra Therapeutics received 19 more outperform votes than Heart Test Laboratories when rated by MarketBeat users. However, 83.33% of users gave Heart Test Laboratories an outperform vote while only 60.00% of users gave Lyra Therapeutics an outperform vote. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes583.33% Underperform Votes116.67%Lyra TherapeuticsOutperform Votes2460.00% Underperform Votes1640.00% Do institutionals & insiders have more ownership in HSCS or LYRA? 17.2% of Heart Test Laboratories shares are owned by institutional investors. Comparatively, 95.6% of Lyra Therapeutics shares are owned by institutional investors. 1.8% of Heart Test Laboratories shares are owned by insiders. Comparatively, 4.7% of Lyra Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, HSCS or LYRA? Heart Test Laboratories has a beta of 2.88, meaning that its share price is 188% more volatile than the S&P 500. Comparatively, Lyra Therapeutics has a beta of -0.14, meaning that its share price is 114% less volatile than the S&P 500. SummaryHeart Test Laboratories and Lyra Therapeutics tied by winning 8 of the 16 factors compared between the two stocks. Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.62M$10.39B$5.84B$9.14BDividend YieldN/A1.39%4.75%3.85%P/E Ratio-0.4718.9326.0419.11Price / Sales246.0045.64447.4676.36Price / CashN/A19.7038.0134.83Price / Book0.335.397.644.62Net Income-$6.61M$284.66M$3.18B$245.85M7 Day Performance-5.63%-4.34%-2.00%-2.61%1 Month Performance5.43%-4.85%-0.44%-2.14%1 Year Performance-68.57%-13.80%16.44%12.98% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories2.4807 of 5 stars$3.69-3.1%$13.50+265.9%-69.2%$3.62M$14,700.00-0.4710Positive NewsGap DownLYRALyra Therapeutics2.0731 of 5 stars$0.21-0.9%$4.50+2,061.4%-95.9%$13.63M$1.56M-0.1450Gap UpALURAllurion Technologies2.3852 of 5 stars$5.12-2.1%$54.17+957.9%-95.3%$13.26M$53.47M-0.43501BLACBellevue Life Sciences AcquisitionN/A$3.01-57.3%N/A-67.4%$12.16MN/A0.00N/AGap UpHigh Trading VolumeLUCYInnovative Eyewear1.9778 of 5 stars$4.94-1.2%$20.00+304.9%-41.7%$12.05M$1.15M-0.519Gap DownSSKNSTRATA Skin Sciences1.162 of 5 stars$2.79-5.3%N/A-46.2%$11.65M$33.36M-1.05120Gap DownIINNInspira Technologies Oxy B.H.N.0.8032 of 5 stars$0.90-1.8%N/A-30.3%$11.30MN/A0.0020INBSIntelligent Bio Solutions0.3388 of 5 stars$2.55+7.6%N/A-45.5%$11.19M$3.11M0.0010News CoverageHigh Trading VolumePOAIPredictive Oncology1.7285 of 5 stars$1.62+9.5%$3.00+85.2%-61.0%$10.81M$1.78M-0.5330BTCYBiotricityN/A$0.43+10.3%N/A-47.1%$10.56M$12.06M-0.3140News CoverageCUTRCutera1.4541 of 5 stars$0.48+14.9%$3.00+523.8%-84.1%$9.71M$212.37M-0.07460Analyst ForecastGap Up Related Companies and Tools Related Companies Lyra Therapeutics Competitors Allurion Technologies Competitors Bellevue Life Sciences Acquisition Competitors Innovative Eyewear Competitors STRATA Skin Sciences Competitors Inspira Technologies Oxy B.H.N. Competitors Intelligent Bio Solutions Competitors Predictive Oncology Competitors Biotricity Competitors Cutera Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSCS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HSCS Stock Alerts